DELRAY BEACH, Fla., July 31, 2025 /PRNewswire/ -- The global Cell Culture Market, valued at US$27.92 billion in 2024 stood at US$29.76 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$50.69 billion by the end of the period. Several factors contribute to the growth of the cell culture market, including growing focus on single-use technologies and increasing demand for novel therapeutics such as mAbs and biosimilars that require mammalian cell lines, which is expected to increase the adoption of cell culture products. Additionally, the growing prevalence of cancer is driving demand in this sector. The increasing support and funding from government and private organizations for cell-based research is also expected to boost growth. Furthermore, established and emerging market players focus on innovating and updating their product portfolios to increase their shares and gain a competitive edge that will likely support market growth in the coming years.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=559
Browse in-depth TOC on "Cell Culture Market"
999 - Tables
57 - Figures
764 - Pages
By products, the cell culture market is segmented into consumables and equipment. Consumables are further segmented into sera, media, reagents; vessels; and accessories. Equipment is further categorized as bioreactors, storage equipment, and other equipment. The consumables segment dominated the market in 2024 and is expected to grow at a higher rate during the forecast. The largest share of the segment is attributed to repetitive purchase of media & reagents, and growing R&D activities to develop and manufacture advanced therapies.
By end users, the cell culture market is segmented into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, research & academic institutes, and other end users. The pharmaceutical & biotechnology companies' segment is estimated to register the highest growth rate during the forecast period. The rising demand for advanced therapies, such as regenerative medicine, due to the increasing prevalence of chronic diseases, is expected to boost the growth of the pharmaceutical & biotechnology companies' segment in the coming years.
By geography, the cell culture market is segmented into six major regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific is anticipated to register the fastest growth in the cell culture owing to the increasing focus on the advancement of the biopharmaceutical industry, high government investments & funding for R&D, and growing demand for cell and gene therapy.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=559
Key players in the cell culture market include Thermo Fisher Scientific Inc. (US), Danaher (US), Sartorius AG (Germany), Merck KGaA (Germany), Corning Incorporated (US), FUJIFILM Holdings Corporation (Japan), BD (US) Eppendorf SE (Germany), Lonza (Switzerland), Getinge AB (Sweden), Agilent Technologies, Inc. (US), HiMedia Laboratories (India), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Solida Biotech GmbH (Germany), Caisson Labs (US), PromoCell GmbH (Germany), InvivoGen (France), PAN-Biotech (Germany), Cellexus (Scotland), Meissner Filtration Products Inc. (US), Adolf Kühner AG (Switzerland), Bio-Techne (US), Advancion Corporation (US), and BioSpherix, Ltd. (US).
Thermo Fisher Scientific Inc. (US):
Thermo Fisher Scientific is a leading provider of scientific solutions, offering a diverse range of products in the cell culture market, including cell culture media, reagents, supplements, and advanced technologies for cell growth and maintenance, enabling researchers to achieve optimal results in their experiments and bioproduction processes. Its leading position is attributed to its strong brand image and robust product portfolio. The company offers its products through well-established brands such as Gibco, Nunc, Countess, Dynabeads, and HyPerforma. It has focused on product launches, expansions, and acquisitions in the last three years. In April 2025, Thermo Fisher Scientific Inc. launched the 5L DynaDrive Single-Use Bioreactor to simplify and accelerate process development.
Danaher (US):
Danaher is a leading life sciences and diagnostics innovator providing a wide range of products and services for medical, industrial, and commercial applications. With this strong global presence, Danaher Corporation is constantly involved in acquisitions and partnerships. For instance, in October 2022, Cytiva acquired CEVEC Pharmaceuticals. This acquisition strengthened Cytiva's position in biomanufacturing solutions and allows its customers to have immediate access to technologies. Additionally, the company emphasizes expanding its capabilities in the cell culture market. In September 2023, Cytiva expanded its facility with the establishment of a new Center of Excellence for single-use technologies in Shanghai. This facility is designed to help advance and accelerate the development of novel therapeutics.
Merck KGaA (Germany)
Merck KGaA offers a wide range of cell culture products, including media, sera, supplements, and reagents, catering to various research, bioprocessing, and clinical applications. They are widely used in biopharmaceutical manufacturing. The company has a strong international presence, with a wide distribution network and established relationships with research institutions, and biotechnology & pharmaceutical companies worldwide. Merck focuses on expanding its presence in emerging markets due to the growing demand for cell culture products. This involves establishing partnerships, distribution networks, and manufacturing facilities in regions such as Asia Pacific and Latin America. In July 2024, Merck invested around USD 7.1 million (EUR 6.6 million) to expand commercial production of its first GMP-compliant manufacturing line for cell culture media (CCM) in China.
For more information, Inquire Now!
Related Reports:
3D Cell Culture Market
Cell Based Assays Market
Single Use Bioprocessing Market
Stem Cell Manufacturing Market
Stem Cell Therapy Market
Get access to the latest updates on Cell Culture Companies and Cell Culture Market Size
About MarketsandMarkets:
MarketsandMarkets has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/cell-culture-market-worth-us50-69-billion-by-2030-with-11-2-cagr--marketsandmarkets-302518435.html
